Inhibition of Human Telomerase by a G-Quadruplex-Interactive Compound
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
ADVERTISEMENT RETURN TO ISSUEPREVLetterNEXTInhibition of Human Telomerase by a G-Quadruplex-Interactive CompoundDaekyu Sun, Brian Thompson, Brian E. Cathers, Miguel Salazar, Sean M. Kerwin, John O. Trent, Terence C. Jenkins, Stephen Neidle, and Laurence H. HurleyView Author Information Institute for Drug Development, 14960 Omicron Drive, San Antonio, Texas 78245-3217, College of Pharmacy, The University of Texas at Austin, Austin, Texas 78712-1074, and CRC Biomolecular Structure Unit, The Institute of Cancer Research, Cotswold Road, Sutton, Surrey SM2 5NG, United Kingdom Cite this: J. Med. Chem. 1997, 40, 14, 2113–2116Publication Date (Web):July 4, 1997Publication History Received25 March 1997Published online4 July 1997Published inissue 1 July 1997https://pubs.acs.org/doi/10.1021/jm970199zhttps://doi.org/10.1021/jm970199zrapid-communicationACS PublicationsCopyright © 1997 American Chemical SocietyRequest reuse permissionsArticle Views5835Altmetric-Citations687LEARN ABOUT THESE METRICSArticle Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.Citations are the number of other articles citing this article, calculated by Crossref and updated daily. Find more information about Crossref citation counts.The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on the Altmetric Attention Score and how the score is calculated. Share Add toView InAdd Full Text with ReferenceAdd Description ExportRISCitationCitation and abstractCitation and referencesMore Options Share onFacebookTwitterWechatLinked InRedditEmail Other access optionsGet e-AlertscloseSupporting Info (1)»Supporting Information Supporting Information SUBJECTS:Chemical structure,G-Quadruplex,Genetics,Inhibition,Peptides and proteins Get e-Alerts
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Several strategies to inhibit telomerase activity have been reported.These include peptide nucleic acids and 2¢-O-MeRNA oligonucleotides directed towards the telomerase RNA template (Herbert et al., 1999), compounds that target telomeric DNA such as cationic porphyrins or anthraquinones (Sun et al., 1997) and nucleosidic reverse transcriptase inhibitors (Strahl and Blackburn, 1996).”
From A highly selective telomerase inhibitor limiting human cancer cell proliferation (2001) · cites this paper as Sun et al., 1997
Citations
Cites
Telomeres shorten during ageing of human fibroblasts
Harley, C. B., Futcher, A. B., & Greider, C. W. (1990) · Nature · doi:10.1038/345458a0 · Cited by 5,750
Structure and function of telomeres
Blackburn, E. H. (1991) · Nature · doi:10.1038/350569a0 · Cited by 3,596
The RNA Component of Human Telomerase
Feng, J., Funk, W. D., Wang, S.-S., Weinrich, S. L., Avilion, A. A., Chiu, C.-P., Adams, R. R., Chang, E., Allsopp, R. C., Yu, J., et al. (1995) · Science · doi:10.1126/science.7544491 · Cited by 2,227
Counter, C. M., Avilion, A. A., LeFeuvre, C. E., Stewart, N. G., Greider, C. W., Harley, C. B., & Bacchetti, S. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05245.x · Cited by 2,096
Inhibition of telomerase by G-quartet DMA structures
Zahler, A. M., Williamson, J. R., Cech, T. R., & Prescott, D. M. (1991) · Nature · doi:10.1038/350718a0 · Cited by 1,134
Divne, C., Ståhlberg, J., Reinikainen, T., Ruohonen, L., Pettersson, G., Knowles, J. K. C., Teeri, T. T., & Jones, T. A. (1994) · Science · doi:10.1126/science.8036495 · Cited by 626
Correlating telomerase activity levels with human neuroblastoma outcomes
Hiyama, E., Hiyama, K., Yokoyama, T., Matsuura, Y., Piatyszek, M. A., & Shay, J. W. (1995) · Nature Medicine · doi:10.1038/nm0395-249 · Cited by 611
Crystal structure of four-stranded Oxytricha telomeric DNA
Kang, C., Zhang, X., Ratliff, R., Moyzis, R., & Rich, A. (1992) · Nature · doi:10.1038/356126a0 · Cited by 555
The High-Resolution Crystal Structure of a Parallel-Stranded Guanine Tetraplex
Laughlan, G., Murchie, A. I. H., Norman, D. G., Moore, M. H., Moody, P. C. E., Lilley, D. M. J., & Luisi, B. (1994) · Science · doi:10.1126/science.8036494 · Cited by 482
Telomerase Activity in Small-Cell and Non-Small-Cell Lung Cancers
Hiyama, K., Hiyama, E., Ishioka, S., Yamakido, M., Inai, K., Gazdar, A. F., Piatyszek, M. A., & Shay, J. W. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.12.895 · Cited by 440
Research works printed but not linked: 10
- Telomeres, 1995, Cold Spring Harbor Press: New York
- Harley C. B., 1994, Cancer. Cold Spring Harbor Symp. Quant. Biol.
- Broccoli D., 1994, Proc. Natl. Acad. Sci. U.S.A., 92, 9086
- Rhyu M. S., 1995, J. Natl. Cancer Inst., 87, 894
- Salazar M., 1996, Biochemistry, 35, 16115
- Fox K. R., 1995, Proc. Natl. Acad. Sci. U.S.A., 92, 7891
- Haq I., 1996, J. Am. Chem. Soc., 118, 10701
- Tanious F. A., 1992, Biochemistry, 31, 11640
- Wang Y., 1992, Biochemistry, 31, 8119
- Chen Q., 1996, Proc. Natl. Acad. Sci. U.S.A., 93, 2639
Cited by
Items 301–400 of 828
Structural Diversity and Specific Recognition of Four Stranded G-Quadruplex DNA
Kaushik, M., Kaushik, S., Bansal, A., Saxena, S., & Kukreti, S. (2011) · Current Molecular Medicine · doi:10.2174/156652411798062421 · Cited by 44
“Since then, wealth of molecular informations being generated from these groups and several other laboratories are increasing continuously at an amazing rate [44-69].”
BackgroundInfluentialRecent advances in the development of telomerase inhibitors for the treatment of cancer
Perry, P. J., & Jenkins, T. C. (1999) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.8.12.1981 · Cited by 43
Self-citationHigh Fidelity Base Pairing at the 3′-Terminus
Patra, A., & Richert, C. (2009) · Journal of the American Chemical Society · doi:10.1021/ja9033654 · Cited by 41
Rocca, R., Talarico, C., Moraca, F., Costa, G., Romeo, I., Ortuso, F., Alcaro, S., & Artese, A. (2017) · Chemical Biology & Drug Design · doi:10.1111/cbdd.13015 · Cited by 41
A Metal‐Mediated Conformational Switch Controls G‐Quadruplex Binding Affinity
Monchaud, D., Yang, P., Lacroix, L., Teulade‐Fichou, M., & Mergny, J. (2008) · Angewandte Chemie · doi:10.1002/ange.200800468 · Cited by 41
Wan, M. S., Fell, P. L., & Akhtar, S. (1998) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1998.8.309 · Cited by 43
“Although other inhibitors have been reported in the literature (Norton et al., 1996; Burger et al., 1997a,b; Sun et al., 1997), our results suggest that synthetic, chemically modified ri-bozymes offer the potential advantages of being highly sequence-specific catalysts that can be administered…”
Bianchi, F., Comez, L., Biehl, R., D’Amico, F., Gessini, A., Longo, M., Masciovecchio, C., Petrillo, C., Rădulescu, A., Rossi, B., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1092 · Cited by 40
“Indeed, G-quadruplex motifs have been proposed to inhibit the reverse-transcriptase enzyme telomerase (4), which is up-regulated in over 85% of cancers but not in somatic cells (5).”
BackgroundCurrent Developments of N-Heterocyclic Carbene Au(I)/Au(III) Complexes toward Cancer Treatment
Tialiou, A., Chin, J. M., Keppler, B. K., & Reithofer, M. R. (2022) · Biomedicines · doi:10.3390/biomedicines10061417 · Cited by 40
“1) structures emerge as a possible drug target, suggesting protein interactions with these structures may lead to possible regulatory effects in telomerase activity [70,71].”
BackgroundMacrocyclic naphthalene diimides as G-quadruplex binders
Marchetti, C., Minarini, A., Tumiatti, V., Moraca, F., Parrotta, L., Alcaro, S., Rigo, R., Sissi, C., Gunaratnam, M., Ohnmacht, S. A., et al. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.03.076 · Cited by 40
Self-citationLacroix, L., Séosse, A., & Mergny, J. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq1199 · Cited by 41
PEG mediated synthesis of amino-functionalised 2,4,6-triarylpyridines
Smith, N. M., Raston, C. L., Smith, C. B., & Sobolev, A. N. (2007) · Green Chemistry · doi:10.1039/b700893g · Cited by 40
Xiong, Y., Su, H.-F., Lv, P., Ma, Y., Wang, S., Miao, H., Liu, H., Tan, J., Ou, T., Gu, L., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5521 · Cited by 42
“G-quadruplex small molecular ligands have the ability to interfere with telomere function in multiple ways: the ligands can inhibit telomerase activity by blocking the binding of telomerase with G-overhang [9]; the ligands can dissociate the shelterin protein complex from the telomere and lead to telomere uncapping an…”
Gunaratnam, M., Green, C. J., Moreira, J. B., Moorhouse, A. D., Kèlland, L. R., Moses, J. E., & Neidle, S. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.03.018 · Cited by 40
“Inhibition of telomerase can be a chieved in an indirect manner by inducing the telomeric DNA substrate to fold into four-stran ded guanine quadruplex structures, using small molecule quadruplex-binding compounds [13].”
BackgroundSelf-citationTelomerase inhibitors: targeting the vulnerable end of cancer?
Kèlland, L. R. (2000) · Anti-Cancer Drugs · doi:10.1097/00001813-200008000-00001 · Cited by 43
“Also, consistent with the need for the four repeats of the d(TTAGGG) telomeric hexanucleotide to be formed prior to G-quadruplex formation, inhibition with inhibitors only occurred after three to four telomere repeats had been synthesized.(93) The more rapid identification of additional quadruplex selective versus dup…”
BackgroundCleavage of Telomeric G-Quadruplex DNA with Perylene-EDTA·Fe(II)
Tuntiwechapikul, W., & Salazar, M. (2001) · Biochemistry · doi:10.1021/bi011363u · Cited by 39
Self-citationRecognition of Chelerythrine to Human Telomeric DNA and RNA G-quadruplexes
Bai, L., Hagihara, M., Nakatani, K., & Jiang, Z. (2014) · Scientific Reports · doi:10.1038/srep06767 · Cited by 38
Aryl ethynyl anthraquinones: a useful platform for targeting telomeric G-quadruplex structures
Percivalle, C., Sissi, C., Greco, M. L., Musetti, C., Mariani, A., Artese, A., Costa, G., Perrore, M. L., Alcaro, S., & Freccero, M. (2014) · Organic & Biomolecular Chemistry · doi:10.1039/c4ob00220b · Cited by 38
Jha, N. S., Mishra, S., Mamidi, A. S., Mishra, A., Jha, S. K., & Surolia, A. (2015) · RSC Advances · doi:10.1039/c5ra17390f · Cited by 38
Rajendran, A., Endo, M., Hidaka, K., Teulade‐Fichou, M., Mergny, J., & Sugiyama, H. (2015) · Chemical Communications · doi:10.1039/c5cc01678a · Cited by 38
Franceschin, M., Lombardo, C. M., Pascucci, E., D’Ambrosio, D., Micheli, E., Bianco, A., Ortaggi, G., & Savino, M. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.11.065 · Cited by 44
Huang, H., Chiu, H., Lee, A.-L., Guo, C.-L., & Yuan, C.-L. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.09.001 · Cited by 38
Applications of telomerase research in the fight against cancer
McKenzie, K. E., Umbricht, C. B., & Sukumar, S. V. (1999) · Molecular Medicine Today · doi:10.1016/s1357-4310(98)01429-4 · Cited by 51
G-Quadruplexes in Human Telomere: Structures, Properties, and Applications
Xu, Y., & Komiyama, M. (2023) · Molecules · doi:10.3390/molecules29010174 · Cited by 37
“It is noteworthy that small molecules targeting G-quadruplexes are also important as potent drugs for therapy of cancer and other diseases [68–79].”
BackgroundPeduto, A., Pagano, B., Petronzi, C., Massa, A., Esposito, V., Virgilio, A., Paduano, F., Trapasso, F., Fiorito, F., Florio, S., et al. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.08.062 · Cited by 37
Arjmand, F., Sharma, S., Parveen, S., TOUPET, L. J., Yu, Z., & Cowan, J. A. (2020) · Dalton Transactions · doi:10.1039/d0dt01527j · Cited by 37
Zhang, W., Chen, M., Wu, Y. L., Tanaka, Y., Ji, Y. J., Zhang, S. L., Wei, C. H., & Xu, Y. (2015) · Scientific Reports · doi:10.1038/srep13693 · Cited by 37
Spinello, A., Barone, G., & Grunenberg, J. (2015) · Physical Chemistry Chemical Physics · doi:10.1039/c5cp05576h · Cited by 37
Huang, H., Chou, C.-L., Guo, C.-L., Yuan, C.-L., Lu, Y.-C., Shieh, F.-Y., & Lin, J. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.12.036 · Cited by 40
Laronze‐Cochard, M., Kim, Y.-M., Brassart, B., Riou, J., Laronze, J., & Sápi, J. (2009) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2009.04.021 · Cited by 37
Telomerase as a new target for the treatment of hormone-refractory prostate cancer
Biroccio, A., & Leonetti, C. (2004) · Endocrine Related Cancer · doi:10.1677/erc.1.00764 · Cited by 40
“Classes of Gquadruplex inhibitors described to date include antraquinones (Sun et al. 1997, Perry et al. 1998a,b), fluorenones (Perry et al. 1999a), acridines (Harrison et al. 1999), cationic porphyrines (Izbicka et al. 1999, Shi et al. 2001), a perylenetetracarboxylic di-imide derivative (Fedoroff…”
BackgroundTargeting DNA G‐Quadruplexes with Helical Small Molecules
Müller, S., Laxmi‐Reddy, K., Jena, P. V., Baptiste, B., Dong, Z., Godde, F., Ha, T., Rodriguez, R., Balasubramanian, S., & Huc, I. (2014) · ChemBioChem · doi:10.1002/cbic.201402439 · Cited by 36
Zagotto, G., Sissi, C., Moro, S., Ben, D. D., Parkinson, G. N., Fox, K. R., Neidle, S., & Palumbo, M. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.09.040 · Cited by 36
Self-citationNagesh, N., Sharma, V. K., Kumar, A. G., & Lewis, E. A. S. (2009) · Journal of Nucleic Acids · doi:10.4061/2010/146418 · Cited by 36
“Few among them are anthraquinones [10], acridines [11], perylenes [12], and triazines [13, 14].”
BackgroundTargeting unimolecular G-quadruplex nucleic acids: a new paradigm for the drug discovery?
Parrotta, L., Ortuso, F., Moraca, F., Rocca, R., Costa, G., Alcaro, S., & Artese, A. (2014) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.941353 · Cited by 40
“[34], who showed that a 2,6-diamidoantraquinone stabilised telomeric G4 structures and inhibited telomerase activity in vitro.”
BackgroundComputational Insights into the Stability and Folding Pathways of Human Telomeric DNA G-Quadruplexes
Luo, D., & Mu, Y. (2016) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.6b01919 · Cited by 36
Selection and Characterization of Malachite Green Aptamers for the Development of Light–up Probes
Wang, H., Wang, J., Sun, N., Cheng, H., Chen, H., & Pei, R. (2016) · ChemistrySelect · doi:10.1002/slct.201600154 · Cited by 36
Short G-rich oligonucleotides as a potential therapeutic for Huntington's Disease
Skogen, M., Roth, J. A., Yerkes, S., Parekh‐Olmedo, H., & Kmiec, E. B. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-65 · Cited by 36
“Such structures are known to inhibit telomerase activity and may explain why telomerase replication/ activity in transformed cells is often absent or reduced [29,30].”
BackgroundAn exonuclease I hydrolysis assay for evaluating G-quadruplex stabilization by small molecules
Yao, Y., Wang, Q., Hao, Y.-H., & Tan, Z. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm194 · Cited by 36
“Stabilization of quadruplex by small molecules has been shown to inhibit telomerase activity (5) and induce growth arrest, senescence and apoptosis in cancer cells (6).”
BackgroundSpotlight on G-Quadruplexes: From Structure and Modulation to Physiological and Pathological Roles
dell’Oca, M. C., Quadri, R., Bernini, G. M., Menin, L., Grasso, L., Rondelli, D., Yazici, O., Sertic, S., Marini, F., Pellicioli, A., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063162 · Cited by 38
“Part of the driving force behind research into G-quadruplex biology originated from early evidence that folded G-quadruplexes inhibit telomerase activity [13,150].”
BackgroundAloe and its Effects on Cancer: A Narrative Literature Review
Manirakiza, A., Laurent, I., & Manirakiza, S. (2021) · East African Health Research Journal · doi:10.24248/eahrj.v5i1.645 · Cited by 40
Ali, J. H., & Walter, M. (2023) · Cancer Cell International · doi:10.1186/s12935-023-03041-2 · Cited by 39
“Bisamidoanthraquinone was the first G4 ligand [101], which was further modified to BSU6039 and Braco-19 with reasonable telomerase inhibitor activities in the 100 nM IC50 range.”
BackgroundA click chemistry approach to C3 symmetric, G-quadruplex stabilising ligands
Moses, J. E., Ritson, D. J., Zhang, F., Lombardo, C. M., Haider, S. M., Oldham, N. J., & Neidle, S. (2010) · Organic & Biomolecular Chemistry · doi:10.1039/c005055e · Cited by 38
Self-citationTelomerase in endocrine and endocrine-dependent tumors
Orlando, C., & Gelmini, S. (2001) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(01)00101-7 · Cited by 35
Macrocyclic Polyoxazoles as G ‐Quadruplex Ligands
Iida, K., & Nagasawa, K. (2013) · The Chemical Record · doi:10.1002/tcr.201300015 · Cited by 34
Rahman, K. M., Tížková, K., Reszka, A. P., Neidle, S., & Thurston, D. E. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.02.020 · Cited by 34
Self-citationLiu, W., Sun, D., & Hurley, L. H. (2005) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770500267238 · Cited by 37
Self-citationHoshyar, R., Bathaie, S. Z., Kyani, A., & Mousavi, M. F. (2012) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2012.730164 · Cited by 34
“[18,19] Herein the effect of these components (crocin, crocetin, picrocrocin, and safranal) on G-quadruplex and I-motif, as two important structures that control replication or transcription, protect chromosome ends, and have a role in recombination,[1,5,10] are considered.”
BackgroundMachado-Pinilla, R., Sánchez‐Pérez, I., Murguía, J. R., Sastre, L., & Perona, R. (2007) · Blood · doi:10.1182/blood-2007-04-083261 · Cited by 34
A small molecule that induces assembly of a four way DNA junction at low temperature
Howell, L. A., Waller, Z. A. E., Bowater, R. P., O'Connell, M. A., & Searcey, M. (2011) · Chemical Communications · doi:10.1039/c1cc12922h · Cited by 34
Uno, T., Aoki, K., Shikimi, T., Hiranuma, Y., Tomisugi, Y., & Ishikawa, Y. (2002) · Biochemistry · doi:10.1021/bi026139z · Cited by 34
Targeting human telomerase for cancer therapeutics
Guittat, L., Alberti, P., Gómez, D., Cian, A. D., Pennarun, G., Lemarteleur, T., Belmokhtar, C., Boujemaa‐Paterski, R., Morjani, H., Trentesaux, C., et al. (2004) · Cytotechnology · doi:10.1007/s10616-004-5127-z · Cited by 39
Telomerase: A Target for Anticancer Therapy
Lichtsteiner, S., LEBKOWSKI, J. S., & Vasserot, A. P. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09395.x · Cited by 36
Solution Structures of a G-Quadruplex Bound to Linear- and Cyclic-Dinucleotides
Winnerdy, F. R., Das, P., Heddi, B., & Phan, A. T. (2019) · Journal of the American Chemical Society · doi:10.1021/jacs.9b05642 · Cited by 33
Zheng, K., Zhang, D., Zhang, L., Hao, Y., Zhou, X., & Tan, Z. (2011) · Journal of the American Chemical Society · doi:10.1021/ja108972e · Cited by 33
Pradeep, T. P., & Barthwal, R. (2016) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2016.06.019 · Cited by 33
Chen, X., Zha, G., Wang, J. Q., & Liu, X. (2018) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2018.1484735 · Cited by 33
Ladame, S., Schouten, J. A., Stuart, J. W., Granadino‐Roldán, J. M., Neidle, S., & Balasubramanian, S. (2004) · Organic & Biomolecular Chemistry · doi:10.1039/b409698c · Cited by 33
Self-citationVo, T. D., Oxenford, S. J., Angell, R. M., Marchetti, C., Ohnmacht, S. A., Wilson, W. D., & Neidle, S. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.0c00041 · Cited by 32
Self-citationMeier‐Stephenson, V., Badmalia, M. D., Mrozowich, T., Lau, K. C. K., Schultz, S. K., Gemmill, D. L., Osiowy, C., van Marle, G., Coffin, C. S., & Patel, T. R. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100589 · Cited by 34
Telomerase inhibitors in cancer therapy: current status and future directions.
Incles, C. M., Schultes, C. M., & Neidle, S. (2003) · PubMed · Cited by 45
Self-citationIsolation of G-Quadruplex DNA Using NMM-Sepharose Affinity Chromatography
Smith, J. S., & Johnson, F. B. (2009) · Methods in molecular biology · doi:10.1007/978-1-59745-363-9_13 · Cited by 32
Kinoshita‐Kikuta, E., Matsubara, R., Katsube, N., Koike, T., & Kimura, E. (2000) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(00)00134-3 · Cited by 32
First International Meeting on Quadruplex DNA
Wilson, W. D., & Sugiyama, H. (2007) · ACS Chemical Biology · doi:10.1021/cb7001686 · Cited by 32
“The meeting coincided with the 10-year anniversary of a publication by the groups of Hurley and Stephen Neidle (University of London) (1).”
BackgroundDesign Principles for Quadruplex-binding Small Molecules
Neidle, S. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-375138-6.00009-1 · Cited by 39
Self-citationBilsland, A. E., Cairney, C. J., & Keith, W. N. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01253.x · Cited by 36
“A diamidoanthraquinone was the first reported GTA, showing slight preference for binding G4 over duplex DNA [10].”
BackgroundG-quadruplexes in mRNA: A key structure for biological function
Kamura, T., Katsuda, Y., Kitamura, Y., & Ihara, T. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.02.168 · Cited by 31
Junctions in DNA: underexplored targets for therapeutic intervention
Ivens, E., Cominetti, M. M. D., & Searcey, M. (2022) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2022.116897 · Cited by 31
“10 The G-quadruplex had been known prior to this, the first crystal structure having been described by Rich.”
Zambre, V. P., Murumkar, P. R., Giridhar, R., & Yadav, M. R. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci900036w · Cited by 32
He, H., Bai, L., & Jiang, Z. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.12.143 · Cited by 31
G-quadruplexes unfolding by RHAU helicase
Gueddouda, N. M., Mendoza, Ó., Gómez, D., Bourdoncle, A., & Mergny, J. (2017) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2017.01.006 · Cited by 31
Ritson, D. J., & Moses, J. E. (2011) · Tetrahedron · doi:10.1016/j.tet.2011.10.066 · Cited by 33
Raymond, É., Soria, J., lzbicka, E., Boussin, F. D., Hurley, L. H., & Hoff, D. D. V. (2000) · Investigational New Drugs · doi:10.1023/a:1006373812586 · Cited by 31
“As a proof of principle, we attempted to introduce the 7-deaza-dGTP nucleoside analog into the G-quadruplex [ 55 ].”
MethodSelf-citationKumar, V., Sengupta, A., Gavvala, K., Koninti, R. K., & Hazra, P. (2014) · The Journal of Physical Chemistry B · doi:10.1021/jp506267b · Cited by 30
Spectroscopic studies of Thioflavin-T binding to c-Myc G-quadruplex DNA
Verma, S., Ghuge, S. A., Ravichandiran, V., & Ranjan, N. (2018) · Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2018.12.044 · Cited by 33
Recent advances in applying G-quadruplex for SARS-CoV-2 targeting and diagnosis: A review
Zhai, L.-Y., Su, A.-M., Liu, J.-F., Zhao, J.-J., Xi, X., & Hou, X. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.09.152 · Cited by 31
“While early studies mainly blocked telomere elongation by targeting telomere G4s in cancer cells [19,20], subsequent research has focused on inhibiting the expression of individual oncogenes by ligands, e.”
Amato, J., Iaccarino, N., Pagano, B., Morigi, R., Locatelli, A., Leoni, A., Rambaldi, M., Zizza, P., Biroccio, A., Novellino, E., et al. (2014) · Frontiers in Chemistry · doi:10.3389/fchem.2014.00054 · Cited by 31
“Furthermore, it has also been demonstrated that molecules that stabilize telomeric G-quadruplexes increase the inhibition of the telomerase (Sun et al., 1997) and lead to telomeric protein uncapping, which, in turn, leads to the onset of DNA damage responses and cellular apoptosis.”
BackgroundInfluentialJäger, K., Bats, J. W., Ihmels, H., Granzhan, A., Uebach, S., & Patrick, B. O. (2012) · Chemistry - A European Journal · doi:10.1002/chem.201103019 · Cited by 30
Suntharalingam, K., Gupta, D., Miguel, P. J. S., Lippert, B., & Vilar, R. (2010) · Chemistry - A European Journal · doi:10.1002/chem.200903501 · Cited by 30
Bhowmik, D., Fiorillo, G., Lombardi, P., & Kumar, G. S. (2015) · Journal of Molecular Recognition · doi:10.1002/jmr.2486 · Cited by 30
“The first evidence that a lowmolecular weight ligand compound could inhibit telomerase activity through G-quadruplex stabilization was shown in 1997, where a G-quadruplex binding anthraquinonebased ligand was shown to reduce telomerase activity in a TRAP based assay (Sun et al., 1997).”
BackgroundLigands of G-quadruplex nucleic acids
Andreeva, D. V., Tikhomirov, A. S., & Shchekotikhin, A. E. (2020) · Russian Chemical Reviews · doi:10.1070/rcr4968 · Cited by 30
A molecular model for drug binding to tandem repeats of telomeric G-quadruplexes
Haider, S. M., & Neidle, S. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370583 · Cited by 30
Self-citationTelomerase as a possible target for anticancer therapy
Autexier, C. (1999) · Chemistry & Biology · doi:10.1016/s1074-5521(99)80122-7 · Cited by 34
Cueny, R. R., McMillan, S. D., & Keck, J. L. (2022) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409238.2023.2181310 · Cited by 29
“Other G4 stabilizers include acridines like BRACO-19, anthraquinones, and fluorenones (Harrison et al. 1999; Perry et al. 1999; Read et al. 2001; D. Sun et al. 1997).”
BackgroundManet, I. G. J., Manoli, F., Donzello, M. P., Viola, E., Andreano, G., Masi, A., Cellai, L., & Monti, S. (2010) · Organic & Biomolecular Chemistry · doi:10.1039/c0ob00598c · Cited by 29
Lee, Y.-R., Yü, D., Liang, Y.-C., Huang, K.-F., Chou, S., Chen, T., Lee, C.-C., Chen, C., Chiou, S., & Huang, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056284 · Cited by 30
Novel ruthenium(ii) polypyridyl complexes as G-quadruplex stabilisers and telomerase inhibitors
Liao, G., Chen, X., Wu, J., Qian, C., Wang, H., Ji, L., & Chao, H. (2014) · Dalton Transactions · doi:10.1039/c3dt53547a · Cited by 30
Targeting telomeres and telomerase
Sun, D., & Hurley, L. H. (2001) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(01)40443-5 · Cited by 34
Self-citationDNA G-Quadruplexes as Targets for Natural Product Drug Discovery
Wang, K., Wang, Y., Dickerhoff, J., & Yang, D. (2024) · Engineering · doi:10.1016/j.eng.2024.03.015 · Cited by 33
“In 1997, human telomerase was found to be inhibited by telomeric-G4-interactive small molecules [6].”
Artese, A., Costa, G., Ortuso, F., Parrotta, L., & Alcaro, S. (2013) · Molecules · doi:10.3390/molecules181012051 · Cited by 31
“Generally, the development of small molecules as G-quadruplex binders has been largely based on polycyclic planar aromatic compounds with at least one substituent terminating in a cationic group [26,27].”
2,6-Diphenylthiazolo[3,2-b][1,2,4]triazoles as telomeric G-quadruplex stabilizers
Bakali, J. E., Klupsch, F., Guédin, A., Brassart, B., Fontaine, G., Farce, A., Roussel, P., Houssin, R., Bernier, J., Chavatte, P., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.05.025 · Cited by 28
Ohnmacht, S. A., Micco, M., Petrucci, V., Todd, A. K., Reszka, A. P., Gunaratnam, M., Carvalho, M. A. B. R., Zloh, M., & Neidle, S. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.07.065 · Cited by 28
Self-citationManet, I. G. J., Manoli, F., Donzello, M. P., Ercolani, C., Vittori, D., Cellai, L., Masi, A., & Monti, S. (2011) · Inorganic Chemistry · doi:10.1021/ic200514z · Cited by 28
Fluorescence Resonance Energy Transfer in the Studies of Guanine Quadruplexes
Juskowiak, B., & Takenaka, S. (2006) · Humana Press eBooks · doi:10.1385/1-59745-069-3:311 · Cited by 28
Raymond, É., Sun, D., Izbicka, E., Mangold, G. L., Silvas, E., Windle, B. E., Sharma, S., Soda, H., Laurence, R., Davidson, K. K., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690526 · Cited by 30
Self-citationSynthesis of a Single G-Quartet Platform in Water
Bare, G. A. L., Liu, B., & Sherman, J. C. (2013) · Journal of the American Chemical Society · doi:10.1021/ja405100z · Cited by 27
Molecular engineering of G-quadruplex ligands based on solvent effect of polyethylene glycol
Wang, Z., & Chang, T. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks578 · Cited by 27
Benz, A., Singh, V., Mayer, T. U., & Hartig, J. S. (2011) · ChemBioChem · doi:10.1002/cbic.201100094 · Cited by 27
G-quadruplex-binding ligand-induced DNA synapsis inside a DNA origami frame
Rajendran, A., Endo, M., Hidaka, K., Tran, P. L. T., Teulade‐Fichou, M., Mergny, J., & Sugiyama, H. (2013) · RSC Advances · doi:10.1039/c3ra45676e · Cited by 27
Ilyinsky, N. S., Shchyolkina, A. K., Borisova, O. F., Mamaeva, O. K., Zvereva, M. I., Azhibek, D. M., Livshits, M. A., Mitkevich, V. A., Balzarini, J. M., Sinkevich, Y. B., et al. (2014) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2014.08.030 · Cited by 30
G-quadruplex ligands: Mechanisms of anticancer action and target binding
Ilyinsky, N. S., Varizhuk, A. M., Beniaminov, A. D., Puzanov, M. A., Shchyolkina, A. K., & Kaluzhny, D. N. (2014) · Molecular Biology · doi:10.1134/s0026893314060077 · Cited by 27
Metadata
- Authors
- Sun, D., Thompson, B., Cathers, B. E., Salazar, M., Kerwin, S. M., Trent, J. O., Jenkins, T. C., Neidle, S., & Hurley, L. H.
- Affiliations
- The University of Texas at Austin (US)
- ORCID
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1997-07-01
- Volume
- 40
- Issue
- 14
- Pages
- 2113-2116
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W2025811126
- Semantic Scholar
- 67b8d8f99c37d9233c470812b601e6637423725f
- Cited by
- 794
- References
- 21
- Citations by year
- 2026: 12 · 2025: 10 · 2024: 29 · 2023: 19 · 2022: 46 · 2021: 46 · 2020: 35 · 2019: 27 · 2018: 27 · 2017: 20 · 2016: 36 · 2015: 42 · 2014: 38 · 2013: 33 · 2012: 39
- FWCI
- 4.39
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- National Institutes of Health (7u19ca067760-05)
- National Cancer Institute (CA-67760, CA 49751)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA and Nucleic Acid Chemistry
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Metal complexes synthesis and properties
- Keywords
- G-quadruplex, human telomerase reverse transcriptase, telomere replication, anticancer agents
- MeSH terms
- Anthraquinones, Base Sequence, DNA, Enzyme Inhibitors, Humans, Nucleic Acid Conformation, Nucleic Acid Denaturation, Oligodeoxyribonucleotides, Molecular Structure, Telomerase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.